Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

نویسندگان

  • Montserrat Garcia-Closas
  • Per Hall
  • Heli Nevanlinna
  • Karen Pooley
  • Jonathan Morrison
  • Douglas A. Richesson
  • Stig E. Bojesen
  • Børge G. Nordestgaard
  • Christen K. Axelsson
  • Jose I. Arias
  • Roger L. Milne
  • Gloria Ribas
  • Anna González-Neira
  • Javier Benítez
  • Pilar Zamora
  • Hiltrud Brauch
  • Christina Justenhoven
  • Ute Hamann
  • Yon-Dschun Ko
  • Thomas Bruening
  • Susanne Haas
  • Thilo Dörk
  • Peter Schürmann
  • Peter Hillemanns
  • Natalia Bogdanova
  • Michael Bremer
  • Johann Hinrich Karstens
  • Rainer Fagerholm
  • Kirsimari Aaltonen
  • Kristiina Aittomäki
  • Karl von Smitten
  • Carl Blomqvist
  • Arto Mannermaa
  • Matti Uusitupa
  • Matti Eskelinen
  • Maria Tengström
  • Veli-Matti Kosma
  • Vesa Kataja
  • Georgia Chenevix-Trench
  • Amanda B. Spurdle
  • Jonathan Beesley
  • Xiaoqing Chen
  • Australian Ovarian Cancer Management Group
  • The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
  • Peter Devilee
  • Christi J. van Asperen
  • Catharina E. Jacobi
  • Rob A. E. M. Tollenaar
  • Petra E.A. Huijts
  • Jan G. M. Klijn
  • Jenny Chang-Claude
  • Silke Kropp
  • Tracy Slanger
  • Dieter Flesch-Janys
  • Elke Mutschelknauss
  • Ramona Salazar
  • Shan Wang-Gohrke
  • Fergus Couch
  • Ellen L. Goode
  • Janet E. Olson
  • Celine Vachon
  • Zachary S. Fredericksen
  • Graham G. Giles
  • Laura Baglietto
  • Gianluca Severi
  • John L. Hopper
  • Dallas R. English
  • Melissa C. Southey
  • Christopher A. Haiman
  • Brian E. Henderson
  • Laurence N. Kolonel
  • Loic Le Marchand
  • Daniel O. Stram
  • David J. Hunter
  • Susan E. Hankinson
  • David G. Cox
  • Rulla Tamimi
  • Peter Kraft
  • Mark E. Sherman
  • Stephen J. Chanock
  • Jolanta Lissowska
  • Louise A. Brinton
  • Beata Peplonska
  • Maartje J. Hooning
  • Han Meijers-Heijboer
  • J. Margriet Collee
  • Ans van den Ouweland
  • Andre G. Uitterlinden
  • Jianjun Liu
  • Low Yen Lin
  • Li Yuqing
  • Keith Humphreys
  • Kamila Czene
  • Angela Cox
  • Sabapathy P. Balasubramanian
  • Simon S. Cross
  • Malcolm W. R. Reed
  • Fiona Blows
  • Kristy Driver
  • Alison Dunning
  • Jonathan Tyrer
  • Bruce A. J. Ponder
  • Suleeporn Sangrajrang
  • Paul Brennan
  • James McKay
  • Fabrice Odefrey
  • Valerie Gabrieau
  • Alice Sigurdson
  • Michele Doody
  • Jeffrey P. Struewing
  • Bruce Alexander
  • Douglas F. Easton
  • Paul D. Pharoah
چکیده

A three-stage genome-wide association study recently identified single nucleotide polymorphisms (SNPs) in five loci (fibroblast growth receptor 2 (FGFR2), trinucleotide repeat containing 9 (TNRC9), mitogen-activated protein kinase 3 K1 (MAP3K1), 8q24, and lymphocyte-specific protein 1 (LSP1)) associated with breast cancer risk. We investigated whether the associations between these SNPs and breast cancer risk varied by clinically important tumor characteristics in up to 23,039 invasive breast cancer cases and 26,273 controls from 20 studies. We also evaluated their influence on overall survival in 13,527 cases from 13 studies. All participants were of European or Asian origin. rs2981582 in FGFR2 was more strongly related to ER-positive (per-allele OR (95%CI) = 1.31 (1.27-1.36)) than ER-negative (1.08 (1.03-1.14)) disease (P for heterogeneity = 10(-13)). This SNP was also more strongly related to PR-positive, low grade and node positive tumors (P = 10(-5), 10(-8), 0.013, respectively). The association for rs13281615 in 8q24 was stronger for ER-positive, PR-positive, and low grade tumors (P = 0.001, 0.011 and 10(-4), respectively). The differences in the associations between SNPs in FGFR2 and 8q24 and risk by ER and grade remained significant after permutation adjustment for multiple comparisons and after adjustment for other tumor characteristics. Three SNPs (rs2981582, rs3803662, and rs889312) showed weak but significant associations with ER-negative disease, the strongest association being for rs3803662 in TNRC9 (1.14 (1.09-1.21)). rs13281615 in 8q24 was associated with an improvement in survival after diagnosis (per-allele HR = 0.90 (0.83-0.97). The association was attenuated and non-significant after adjusting for known prognostic factors. Our findings show that common genetic variants influence the pathological subtype of breast cancer and provide further support for the hypothesis that ER-positive and ER-negative disease are biologically distinct. Understanding the etiologic heterogeneity of breast cancer may ultimately result in improvements in prevention, early detection, and treatment.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic susceptibility loci for breast cancer by estrogen receptor status.

Breast cancer is a heterogeneous disease, and risk factors could be differentially associated with the development of distinct tumor subtypes that manifest different biological behavior and progression. In support of this view, there is growing evidence that known breast cancer risk factors vary by hormone receptor status and perhaps other pathologic characteristics of disease. Recent work from...

متن کامل

Association between HIC1 and RASSF1A Promoter Hypermethylation with MTHFD1 G1958A Polymorphism and Clinicopathological Features of Breast Cancer in Iranian Patients

Background: Ras-associated domain family 1 (RASSF1A) and hypermethylated in cancer (HIC1) genes are methylated more frequently in breast cancer. Genetic factors that alter the DNA methylation levels in normal and tumor tissues could therefore influence the susceptibility to this tumor phenotype. Objective: We determined the frequency of aberrant methylation of HIC1 and RASSF1A gene promoters an...

متن کامل

Genetic polymorphism of N142D GSTO2 and susceptibility to breast cancer: a meta-analysis

To establish a comprehensive picture of the relationship between glutathione S-transferase omega 2 (GSTO2; MIM: 612314) gene N142D variant (rs. 156697) and breast cancer risk, the present meta-analysis was carried out. Studies published up to July 2012 with information about GSTO2 polymorphism and breast cancer risk were identified using several electronic databases. We identified 4 eligible st...

متن کامل

Correlation of 4-1BBL+ B Cells in Tumor Draining Lymph Nodes with Pathological Characteristics of Breast Cancer

Background: B cells can increase the expression of granzyme B in CD8+ T cells through 4-1BBL/4-1BB interaction and promote anti-tumor immunity. Objective: To investigate the expression of 4-1BBL on B cells in the breast tumor draining lymph nodes (TDLNs) and its association with disease parameters. Methods: Using Ficoll-Hypaque gradi...

متن کامل

Study of the association FokI polymorphisms of the XRCC3 gene with the risk of breast cancer in women: brief report

Background: Breast cancer is one of the most common worldwide malignancies among women. Biological data suggest that damage induced by endogenous and exogenous factors affects the integrity of DNA and associated with susceptibility to breast cancer. Single nucleotide polymorphisms (SNPs) in DNA repair genes can associated with differences in the repair efficiency of DNA damage and may affect br...

متن کامل

Hypermethylation of E-Cadherin and Estro-gen Receptor- Gene Promoter and Its Association with Clinicopathological Features of Breast Cancer in Iranian Patients

Background: Aberrant methylation of cytosine-guanine dinucleotide islands leads to inactivation of tumor suppressor genes in breast cancer. Tumor suppressor genes are unmethylated in normal tissue and often become hypermethylated during tumor formation, leading to gene silencing. We investigated the association between E-cadherin (CDH1) and estrogen receptor-α (ESRα) gene promoter methylation a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • PLoS Genetics

دوره 4  شماره 

صفحات  -

تاریخ انتشار 2008